740 Y-P(TFA)
CAS No. ——
740 Y-P(TFA)( 740YPDGFR(TFA),PDGFR 740Y-P(TFA) )
Catalog No. M22770 CAS No. ——
740 Y-P(TFA) is a potent and cell-permeable activator of PI3K.740 Y-P is a synthetic biotinylated peptide.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 312 | In Stock |
|
| 10MG | 521 | In Stock |
|
| 25MG | 670 | In Stock |
|
| 50MG | 1040 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name740 Y-P(TFA)
-
NoteResearch use only, not for human use.
-
Brief Description740 Y-P(TFA) is a potent and cell-permeable activator of PI3K.740 Y-P is a synthetic biotinylated peptide.
-
Description740 Y-P(TFA) is a potent and cell-permeable activator of PI3K.740 Y-P is a synthetic biotinylated peptide. 740 Y-P stimulates mitogenesis at the lowest concentration tested (1 mg/mL). The peptide stimulates mitogenesis in both the presence and absence of serum (0.5%) and in the former instance, a maximal response observed at 50 mg/mL. 740Y-P peptide to stimulate mitogenesis is highly specific and not a general feature of a cell-permeable SH2 domain-binding peptide. 740Y-P is as effective as a growth factor (FGF2) at promoting neuronal cell survival via the established PI 3-kinase-Akt survival cascade. Stimulation of neuronal cell survival by the PDGFR740Y-P peptide is dose-dependent and does not require insulin.
-
In Vitro——
-
In Vivo——
-
Synonyms740YPDGFR(TFA),PDGFR 740Y-P(TFA)
-
PathwayPI3K/Akt/mTOR signaling
-
TargetPI3K
-
RecptorPI3K
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number——
-
Formula Weight——
-
Molecular Formula——
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Derossi D, et al. Stimulation of mitogenesis by a cell-permeable PI 3-kinase binding peptide. Biochem Biophys Res Commun. 1998 Oct 9;251(1):148-52.
molnova catalog
related products
-
BGT226 free base
Bgt226 is a novel dual PI3K / mTOR inhibitor, it acts on PI3K α/β/γ with IC50 of 4 nM / 63 nM / 38 nM, respectively.
-
mTOR inhibitor 9d
mTOR inhibitor 9d is a dual inhibitor of the protein kinases mTOR and PI3K with an mTOR IC50 value of 0.31 nm, and can be used for the treatment of leukemia, skin cancer, breast cancer, lung cancer and colon cancer.
-
PI3K-IN-38
PI3K-IN-38 is an orally available and potent PI3K inhibitor with an IC50 value of 0.541 μM for PI3K-α. PI3K-IN-38 exhibits anticancer and anti-inflammatory activity and inhibits tumor growth in vivo.
Cart
sales@molnova.com